170 likes | 494 Views
Intrathecal Baclofen in Children with CP and Dystonia The NUH Experience. . BASICS. GABA: inhibitory neurotransmittorBaclofen: increases the effect of GABA in the nervous systemDeveloped in 1920Intrathecal use since 1970'sDrug delivery systems since 1980's. HOW. Programmable implantable pump,
E N D
1. ECMT January 2007Michael VloeberghsProfessor of Paediatric NeurosurgeryNottingham University Hospital
2. Intrathecal Baclofen in Children with CP and DystoniaThe NUH Experience
3. BASICS GABA: inhibitory neurotransmittor
Baclofen: increases the effect of GABA in the nervous system
Developed in 1920
Intrathecal use since 1970s
Drug delivery systems since 1980s
4. HOW Programmable implantable pump, Synch II
Catheter, going from pump to spinal sack
Baclofen is delivered near the spinal cord
The dose necessary for effect is 1/1000 of the oral dose
Limited by reservoir volume
5. WHO Proven benefit: Quadriparetics with severe spasticity
Unproven benefit: Ambulant patients
Historically: ITB in children was seen as experimental in 1998
Postcode lottery, funding restrictions, various hurdles
6. EFFECTS Improvement of nursing care
Improved interactivity
Improved swallowing
Improved ease of motion
Improved function?
Effect lies in the eye of the beholder
The test procedure is predictive of outcome
7. Nottingham Activity Referral
Test Procedure,
EUA (neuromuscular block)
Negotiation Phase
Implant
Refill Procedure
10/1998 First tests & implants started
8. Test Procedure- Effects Improvement of nursing care
Improved interactivity
Improved swallowing
Improved ease of motion
Improved function?
Effect lies in the eye of the beholder
The test procedure is predictive of outcome
Clear goals
Negotiation
9. ITB Implant Programmable implantable pump,
Medtronic Synchromed II
Catheter, going from pump to spinal sack
Baclofen is delivered near the spinal cord
The dose necessary for effect is 1/1000 of the oral dose
Limited by reservoir volume
11. TEST PROCEDURE Examination under anaesthetic, catheter insertion, single injection of 50 mcgs ITB
Total tests: 164
No effect of Baclofen: 12
Good effect of Baclofen, implant declined: 15
No adverse events
No side effects
No infections
10% spinal tap syndrome
Awaiting funding: > 50
12. NUH Implants 147 implants in 137 children
127 CP, birth-injury-prematurity
8 Dystonia
2 Familial Paraparesis
2 Transverse Myelitis
1 TBI
1 NAI
1 Near Drowning
1 Encephalitis
13. Distribution Male: 80
Female: 57
Subcutaneous: 5
Subfascial: 142
Synchromed EL 10 ml: in use 66
Synchromed II 20 ml: 81
Single piece catheter
Tip position irrelevant
Cervical catheter implant 4
14. Dystonia Primary : 6
2 PKAN
2 Unknown
1 Glutaraciduria
1 Leys syndrome
3 have DBS in place
Secondary : 2
Posturing
Bulbar signs
Athetoid
15. ADVERSE EVENTS Catheter migration : 16 per procedure: 10,1%
Fracture catheter connector: 5 (EL) 3,4%
Infection: 3 + 1 (1 sterile pus) 2,7%
Cut catheter 2, 1 spin proc., 1 iatrogen.
Psychosis: 1
GI Side effects on dose increment: 1
Sedation: 1
Death unrelated to ITB: 5 UNK: 1
TOR: 6
End Battery Life: 2
Minor events: small number without consequence
No adverse events with refills,1998- 2006
No adverse events with Cervical Catheter test or implant.
16. CONCLUSION ITB is safe, has a number of adverse events but these lie well in the brackets of the international literature
NUH has the largest global experience with ITB in Children
The ITB team aims to improve the service and continue to collect data on ITB